Streetbeat News

Products Services

OPTHF

PBM

Psyence Biomedical Ltd. (NASDAQ:PBM) is advancing its psychedelic-based mental health solutions with a Phase IIb trial in Australia and the acquisition of Clairvoyant. The company is also partnering with Optimi Health (OTC:OPTHF) for psilocybin supply, aiming for significant data readouts in 2025.

Portfolio Pulse from Juan Spínelli

September 16, 2024 | 5:42 pm

ADBE

CRM

Adobe Inc (NASDAQ:ADBE) exceeded Q3 expectations but issued a cautious Q4 guidance, causing concerns about competition and market conditions. Despite strong revenue growth and AI integration, Adobe's forecast fell short of estimates, impacting its stock.

Portfolio Pulse from Upwallstreet

September 16, 2024 | 5:41 pm

LLY

Eli Lilly's Ebglyss, a new eczema treatment, has received FDA approval. The drug targets inflammation and is suitable for patients 12 years and older. Clinical trials showed significant improvement in skin clarity and itch relief. LLY stock saw a slight increase following the news.

Portfolio Pulse from Vandana Singh

September 16, 2024 | 5:36 pm

AAPL

PCG

PG&E customers can now access their electricity usage data through Apple's Home app on various Apple devices, allowing them to make informed decisions about their energy consumption.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 5:36 pm

BMRN

BioMarin Pharmaceutical shares are experiencing a decline due to strong clinical data from Ascendis Pharma's competing dwarfism drug.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 5:26 pm

ZM

Zoom has expanded its offerings for government use by receiving FedRAMP JAB authorization for its AI Companion and Zoom Contact Center. This enhances Zoom's position in the U.S. government sector, providing secure AI solutions for federal, state, and local agencies.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 5:25 pm

AAPL

AFRM

Affirm is now integrated with Apple Pay, allowing U.S. consumers to split purchases into biweekly or monthly payments with 0% APR on iPhone and iPad using iOS 18 and iPadOS 18.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 5:17 pm

SPY

The White House, through Brainard, announced that President Biden's targeted tariff hikes on Chinese goods are intended to support the development of clean energy manufacturing and protect strategic industries in the U.S. This was discussed at a Council on Foreign Relations event.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 5:17 pm

SWKS

Skyworks Solutions (NASDAQ:SWKS) has seen significant options trading activity, with 15 unusual trades identified. The sentiment is mixed, with 46% bullish and 26% bearish. The price target for SWKS is between $75.0 and $101.0. The stock is currently down 2.88% at $99.52, with RSI indicators suggesting it may be oversold.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 5:15 pm

NFLX

Whales are showing a bearish stance on Netflix (NFLX) with 43% of options trades being bearish. The stock is currently trading at $694.38, with analysts setting a price target between $750 and $900. Netflix's business model focuses on streaming services, and it recently introduced ad-supported plans.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 5:15 pm